New Gene Therapy Redefines Hemophilia B Treatment
BBM-H901, a breakthrough gene therapy for hemophilia B, is now approved on the Chinese mainland, offering a lasting treatment solution.
GeneTherapy
Read More
China’s Breakthroughs Slash Rare Disease Diagnosis Time and Costs
China revolutionizes rare disease management by reducing diagnosis time from four years to under four weeks and cutting medical expenses by 90%, enhancing lives globally.